South & Central America Deep Brain Simulation Market Forecast to 2030

South & Central America Deep Brain Simulation Market Forecast to 2030

South & Central America Deep Brain Simulation Market Forecast to 2030 – Regional Analysis – by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson’s Disease, Tremor, Dystonia, Epilepsy, Alzheimer’s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)

Send Enquiry
Item ID: BMIRE00029295 Category: Tag:

$2,485 – $3,885

Description

The South & Central America deep brain simulation market is expected to grow from US$ 27.53 million in 2022 to US$ 50.95 million by 2030. It is estimated to grow at a CAGR of 8.0% from 2022 to 2030.

Increasing Demand for Minimally Invasive Surgery Drive South & Central America Deep Brain Simulation Market

Deep brain stimulation is a minimally invasive targeted surgery used to treat movement disorders in dystonia, Parkinson’s disease, and essential tremor. Minimally invasive surgeries (MIS) offer several advantages over traditional surgical techniques. MIS minimizes trauma to the body, reduces postoperative pain, increases recovery speed, and improves outcomes. Robotic procedures represent the latest evolution in minimally invasive procedures, providing surgeons with precision equipment that uses the same small incisions used in traditional laparoscopy. MIS leads to less blood loss, less analgesic use, and shorter postoperative hospital stay than open surgery. In addition, minimally invasive surgery indicates a higher accuracy rate than traditional surgical methods. Also, these procedures require tiny incisions large enough to insert thin tubes and cameras. These benefits of MIS are increasing inpatients and have encouraged older patients who face high operative morbidity and mortality to seek surgery. Thus, the rising demand for minimally invasive surgeries due to their advantages bolsters the South & Central America deep brain stimulation (DBS) market growth.

South & Central America Deep Brain Simulation Market Overview

In Brazil, the aging population is rapidly growing. According to the data from Pan American Health Organization (PAHO), Brazil has over 30 million people aged 60 years and older, representing 13% of the country’s population. By 2030, this age group is expected to reach ~50 million, representing 24% of the Brazilian population. As per the Brazil Statistical Institute, the country’s population aged 65 and above is expected to hold 36% share of the total population of Brazil by 2050. Further, the prevalence of neurological disorders is dependent on the geriatric population in Brazil; thus, the increasing incidences of neurological diseases, such as Parkinson’s disease and Alzheimer’s disease, are likely to propel the demand for deep brain stimulation (DBS) for treatment. Moreover, as per the study, “Trends in mortality from Alzheimer’s disease in Brazil, 2000-2019,” published in 2023, in Brazil, Alzheimer’s disease has become a major health concern since the population is increasingly aging, coupled with the increasing mortality rates and the growing prevalence of the disease in the country. During 2009-2019, there was a 49% increase in deaths due to Alzheimer’s disease in the country, making it the seventh leading cause of death. More than 211,600 deaths were due to the disease in the same period in Brazil. Furthermore, 73% of the deaths were of people aged 80 and above, and 27% were in the 60-79 age group. Thus, the above-mentioned factors are expected to increase the demand for DBS devices for the treatment of diseases in the country in the coming years.

South & Central America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Deep Brain Simulation Market Segmentation

The South & Central America deep brain simulation market is segmented into product, application, end user, and country.

Based on product, the South & Central America deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the South & Central America deep brain simulation market.

Based on application, the South & Central America deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. In 2022, the Parkinson’s disease segment registered the largest share in the South & Central America deep brain simulation market.

Based on end user, the South & Central America deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the South & Central America deep brain simulation market.

Based on country, the South & Central America deep brain simulation market is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2022, Brazil registered the largest share in the South & Central America deep brain simulation market.

Abbott, Medtronic, Boston Sci, and Leva Nova are some of the leading companies operating in the South & Central America deep brain simulation market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 8.0% CAGR, the South & Central America Deep Brain Simulation Market is Speculated to be worth US$ 50.95 million by 2030, says the research team

According to the research team’ research, the South & Central America deep brain simulation market was valued at US$ 27.53 million in 2022 and is expected to reach US$ 50.95 million by 2030, registering a CAGR of 8.0% from 2022 to 2030. Growing research and development activities and increasing demand for minimally invasive surgery are among the critical factors attributed to the South & Central America deep brain simulation market expansion.

Advances in atlases, imaging techniques, and connectomics improve DBS targeting strategies. Improvements in lead design can make it possible to use segmented contacts for directional stimulation, and improvements in implantable pulse generator (IPG) design can result in small, longer-lasting magnetic resonance imaging (MRI) compatible batteries. Software advances can enable various programming strategies to improve efficacy while minimizing stimulation-related side effects and maximizing battery life. Brain recognition will help clinicians and researchers understand the physiological aspects of DBS and potentially act as another programming strategy. Closed-loop DBS can help tailor stimulation parameters to individual symptoms. In addition, remote and virtual programming could become more viable and accessible. DBS technology is widely used to treat various diseases and symptoms, and research is ongoing to improve current designs. Major market players are focused on introducing updated versions of their already approved DBS devices. On May 24, 2022, Great Lakes NeuroTechnologies (GLNT), a diagnostic and therapeutic system provider, announced that it had initiated a multi-center research study to collect data to improve its Kinesia motor assessment technology, specifically to determine when a patient of Parkinson’s disease (PD) is ready to consider advanced therapy such as deep brain stimulation (DBS) or an implantable drug pump and to identify when a patient needs therapy adjustment. The therapy is recommended when oral medications no longer relieve motor symptoms, including stiffness, slow movements, falls and dizziness, freezing, muscle spasms, and dystonia. Therefore, rising research and development activities in the field of deep brain stimulation are expected to bolster the South & Central America deep brain stimulation market growth in the future.

On the contrary, side effects associated with deep brain stimulation hurdles the growth of South & Central America deep brain simulation market.

Based on product, the South & Central America deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. The dual channel deep brain stimulator segment held 50.0% share of South & Central America deep brain simulation market in 2022, amassing US$ 13.77 million. It is projected to garner US$ 27.49 million by 2030 to expand at 9.0% CAGR during 2022-2030.

Based on application, the South & Central America deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. The Parkinson’s disease segment held 67.5% share of South & Central America deep brain simulation market in 2022, amassing US$ 20.47 million. It is projected to garner US$ 38.12 million by 2030 to expand at 8.1% CAGR during 2022-2030.

Based on end user, the South & Central America deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. The hospitals segment held 56.0% share of South & Central America deep brain simulation market in 2022, amassing US$ 15.41 million. It is projected to garner US$ 29.89 million by 2030 to expand at 8.6% CAGR during 2022-2030.

Based on country, the South & Central America deep brain simulation market is segmented into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 59.5% share of South & Central America deep brain simulation market in 2022. It was assessed at US$ 16.37 million in 2022 and is likely to hit US$ 30.84 million by 2030, exhibiting a CAGR of 8.2% during 2022-2030.

Key players operating in the South & Central America deep brain simulation market are Abbott, Medtronic, Boston Sci, and Leva Nova, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America deep brain simulation market.
o Highlights key in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America deep brain simulation market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the deep brain simulation market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 South & Central America Deep Brain Stimulation Market, by Country (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Deep Brain Simulation Market Landscape
4.1 Overview
4.2 South & Central PEST Analysis
4.3 Comparison Analysis
4.3.1 Comparison of Deep Brain Stimulation and Lesioning Procedures
4.3.2 Lesioning Procedures in Neurological Disorders
4.3.3 South & Central America Deep Brain Stimulation and Lesion Surgeries 2022, By Volume
4.3.4 South & Central America Deep Brain Stimulation Surgical Procedures Performed in 2022, By Country
5. South & Central America Deep Brain Simulation Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Rising Prevalence of Neurological Disorders
5.1.2 Increasing Demand for Minimally Invasive Surgery
5.2 Market Restraints
5.2.1 Side Effects Associated with Deep Brain Stimulation
5.3 Market Opportunities
5.3.1 Technological Advancements and Approvals in Deep Brain Stimulation
5.4 Future Trends
5.4.1 Growing Research and Development Activities
5.5 Impact Analysis
6. Deep Brain Simulation Market – South & Central America Market Analysis
6.1 South & Central America Deep Brain Simulation Market Revenue (US$ Mn), 2022 – 2030
7. South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 South & Central America Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Single Channel Deep Brain Stimulator
7.3.1 Overview
7.3.2 Single Channel Deep Brain Stimulator: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Dual Channel Deep Brain Stimulator
7.4.1 Overview
7.4.2 Dual Channel Deep Brain Stimulator: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Software and Accessories
7.5.1 Overview
7.5.2 Software and Accessories: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 South & Central America Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Parkinson\’s Disease
8.3.1 Overview
8.3.2 Parkinson\’s Disease: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Tremor
8.4.1 Overview
8.4.2 Tremor: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer\’s Disease
8.5.1 Overview
8.5.2 Alzheimer\’s Disease: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Dystonia
8.6.1 Overview
8.6.2 Dystonia: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Epilepsy
8.7.1 Overview
8.7.2 Epilepsy: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 South & Central America Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Neurology Clinics
9.4.1 Overview
9.4.2 Neurology Clinics: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Deep Brain Simulation Market – Country Analysis
10.1 Overview
10.1.1.1 South & Central America Deep Brain Simulation Market by Country
10.1.1.2 Brazil
10.1.1.2.1 Overview
10.1.1.2.2 Brazil Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Brazil Deep Brain Simulation Market, by Product
10.1.1.2.4 Brazil Deep Brain Simulation Market, by Application
10.1.1.2.5 Brazil Deep Brain Simulation Market, by End User
10.1.1.3 Argentina
10.1.1.3.1 Overview
10.1.1.3.2 Argentina Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Argentina Deep Brain Simulation Market, by Product
10.1.1.3.4 Argentina Deep Brain Simulation Market, by Application
10.1.1.3.5 Argentina Deep Brain Simulation Market, by End User
10.1.1.4 Rest of South & Central America
10.1.1.4.1 Overview
10.1.1.4.2 Rest of South & Central America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Rest of South & Central America Deep Brain Simulation Market, by Product
10.1.1.4.4 Rest of South & Central America Deep Brain Simulation Market, by Application
10.1.1.4.5 Rest of South & Central America Deep Brain Simulation Market, by End User
11. South & Central America Deep Brain Simulation Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in Deep Brain Stimulation Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. South & Central America Deep Brain Simulation Market, Key Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 LivaNova Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. South & Central America Deep Brain Simulation Market Segmentation
Table 2. Comparison of Deep Brain Stimulation and Lesioning Procedures
Table 3. South & Central America Deep Brain Stimulation Surgeries and Lesion Surgeries Volume in 2022
Table 4. South & Central America Deep Brain Stimulation Surgical Procedures Performed in 2022, by Country.
Table 5. Brazil Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 6. Brazil Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 7. Brazil Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 8. Argentina Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 9. Argentina Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 10. Argentina Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 11. Rest of South & Central America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 12. Rest of South & Central America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 13. Rest of South & Central America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 14. Recent Organic Growth Strategies in Deep Brain Stimulation Market
Table 15. Recent Inorganic Growth Strategies in the Deep Brain Stimulation Market
Table 16. Glossary of Terms, South & Central America Deep Brain Simulation Market

LIST OF FIGURES

Figure 1. South & Central America Deep Brain Simulation Market Segmentation, By Country
Figure 2. South & Central America – PEST Analysis
Figure 3. South & Central America Deep Brain Simulation Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. South & Central America Deep Brain Simulation Market Revenue (US$ Mn), 2022 – 2030
Figure 6. South & Central America Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
Figure 7. Single Channel Deep Brain Stimulator: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Dual Channel Deep Brain Stimulator: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Software and Accessories: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. South & Central America Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
Figure 11. Parkinson\’s Disease: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Tremor: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Alzheimer\’s Disease: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Dystonia: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. South & Central America Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 18. Hospitals: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Neurology Clinics: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Ambulatory Surgical Centers: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: South & Central America Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. South & Central America Deep Brain Simulation Market, By Country, 2022 ($Mn)
Figure 23. South & Central America Deep Brain Simulation Market, By Key Countries, 2022 And 2030 (%)
Figure 24. Brazil Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Argentina Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Rest of South & Central America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Growth Strategies in Deep Brain Stimulation Market

The List of Companies – South & Central America Deep Brain Simulation Market

1. Abbott Laboratories
2. Medtronic Plc
3. Boston Scientific Corp
4. LivaNova, PLC

Reviews

There are no reviews yet.

Be the first to review “South & Central America Deep Brain Simulation Market Forecast to 2030”